TG and Graves disease: The data were acquired in a retrospective study entitled, ‘Elucidating the dose response relationship of thyroid hormone to anti-thyroid drugs in Graves' disease', and ethically approved by the Domain Specific Review Board (DSRB reference code—C/2011/02012) of National Healthcare Group, Singapore.